Cyclophosphamide

NDC 10019-955 · Baxter Healthcare Company

Generic namecyclophosphamide

Dosage formINJECTION, POWDER, FOR SOLUTION

RouteINTRAVENOUS, ORAL

Active ingredient(s)CYCLOPHOSPHAMIDE

Strength500 mg/25mL

Marketing categoryANDA

Packages

10019-955-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (10019-955-01) / 25 mL in 1 VIAL, SINGLE-DOSE (10019-955-50)

J9075 — Injection, cyclophosphamide, not otherwise specified, 5 mg Medicare Part B payment limit (ASP + 6%): $0.57

FDA lists these products with the same active ingredient.

0781-3530 — Cyclophosphamide, 10019-935 — cyclophosphamide, 10019-936 — cyclophosphamide, 10019-937 — cyclophosphamide, 10019-938 — cyclophosphamide, 10019-939 — cyclophosphamide, 10019-942 — cyclophosphamide, 10019-943 — cyclophosphamide, 10019-944 — cyclophosphamide, 10019-945 — cyclophosphamide, 10019-956 — cyclophosphamide, 10019-957 — cyclophosphamide, 10019-982 — Cyclophosphamide, 10019-984 — Cyclophosphamide, 14335-470 — Cyclophosphamide for Injection, 14335-471 — Cyclophosphamide for Injection, 14335-472 — Cyclophosphamide for Injection, 14789-125 — Cyclophosphamide, 14789-126 — Cyclophosphamide, 16714-857 — cyclophosphamide, +62 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.